Free Trial
NYSE:EHC

Encompass Health (EHC) Stock Price, News & Analysis

Encompass Health logo
$113.33 +11.92 (+11.75%)
Closing price 04/25/2025 03:59 PM Eastern
Extended Trading
$113.09 -0.24 (-0.21%)
As of 04/25/2025 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Encompass Health Stock (NYSE:EHC)

Key Stats

Today's Range
$108.25
$114.38
50-Day Range
$93.57
$113.33
52-Week Range
$82.09
$114.38
Volume
2.08 million shs
Average Volume
675,826 shs
Market Capitalization
$11.41 billion
P/E Ratio
25.41
Dividend Yield
0.60%
Price Target
$113.14
Consensus Rating
Buy

Company Overview

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions. It offers services through the Medicare program to federal government, managed care plans and private insurers, state governments, and other patients. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. The company was incorporated in 1984 and is based in Birmingham, Alabama.

Encompass Health Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
77th Percentile Overall Score

EHC MarketRank™: 

Encompass Health scored higher than 77% of companies evaluated by MarketBeat, and ranked 148th out of 916 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Encompass Health has received a consensus rating of Buy. The company's average rating score is 3.11, and is based on 8 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Encompass Health has only been the subject of 4 research reports in the past 90 days.

  • Read more about Encompass Health's stock forecast and price target.
  • Earnings Growth

    Earnings for Encompass Health are expected to grow by 10.00% in the coming year, from $4.80 to $5.28 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Encompass Health is 25.41, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 21.67.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Encompass Health is 25.41, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 22.14.

  • Price to Earnings Growth Ratio

    Encompass Health has a PEG Ratio of 2.31. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Encompass Health has a P/B Ratio of 4.09. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    2.19% of the float of Encompass Health has been sold short.
  • Short Interest Ratio / Days to Cover

    Encompass Health has a short interest ratio ("days to cover") of 3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Encompass Health has recently increased by 4.81%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Encompass Health has a dividend yield of 0.69%, which is in the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Encompass Health does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of Encompass Health is 15.25%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, Encompass Health will have a dividend payout ratio of 12.88% next year. This indicates that Encompass Health will be able to sustain or increase its dividend.

  • Read more about Encompass Health's dividend.
  • Percentage of Shares Shorted

    2.19% of the float of Encompass Health has been sold short.
  • Short Interest Ratio / Days to Cover

    Encompass Health has a short interest ratio ("days to cover") of 3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Encompass Health has recently increased by 4.81%, indicating that investor sentiment is decreasing.
  • News Sentiment

    Encompass Health has a news sentiment score of 1.08. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.74 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 27 news articles for Encompass Health this week, compared to 8 articles on an average week.
  • Search Interest

    Only 3 people have searched for EHC on MarketBeat in the last 30 days. This is a decrease of -40% compared to the previous 30 days.
  • MarketBeat Follows

    Only 4 people have added Encompass Health to their MarketBeat watchlist in the last 30 days. This is a decrease of -43% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Encompass Health insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $495,578.00 in company stock.

  • Percentage Held by Insiders

    Only 2.10% of the stock of Encompass Health is held by insiders.

  • Percentage Held by Institutions

    97.25% of the stock of Encompass Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Encompass Health's insider trading history.
Receive EHC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Encompass Health and its competitors with MarketBeat's FREE daily newsletter.

EHC Stock News Headlines

Encompass Health price target raised to $122 from $120 at KeyBanc
Trump purposefully forcing markets to crash…
Whether you agree with the plan or not doesn’t matter. It’s happening. The only question is – are you ready for it?
Encompass Health names Patrick Tuer as COO, effective immediately
Encompass Health reports Q1 adjusted EPS $1.37, consensus $1.19
Encompass Health reports results for first quarter 2025
See More Headlines

EHC Stock Analysis - Frequently Asked Questions

Encompass Health's stock was trading at $92.35 at the beginning of the year. Since then, EHC shares have increased by 22.7% and is now trading at $113.33.
View the best growth stocks for 2025 here
.

Encompass Health Co. (NYSE:EHC) issued its earnings results on Thursday, April, 24th. The company reported $1.37 EPS for the quarter, beating analysts' consensus estimates of $1.19 by $0.18. The business had revenue of $1.46 billion for the quarter, compared to analyst estimates of $1.43 billion. Encompass Health had a trailing twelve-month return on equity of 17.56% and a net margin of 8.48%.
Read the conference call transcript
.

Encompass Health's board initiated a stock repurchase program on Wednesday, July 24th 2024, which permits the company to repurchase $500,000,000 in outstanding shares, according to EventVestor. This means that the company could reacquire up to 5.4% of its stock through open market purchases. Stock buyback programs are often an indication that the company's board of directors believes its shares are undervalued.

Encompass Health subsidiaries include these companies: Baptist Outpatient Services Inc., Frontier Home Health and Hospice, Generation Solutions of Lynchburg LLC, Alacare Home Health & Hospice, Camellia Healthcare, CareSouth Health System Inc., Reliant Hospital Partners LLC, and others.

Encompass Health's top institutional investors include Copeland Capital Management LLC (1.25%), Sumitomo Mitsui Trust Group Inc. (0.76%), Reinhart Partners LLC. (0.56%) and Fort Washington Investment Advisors Inc. OH (0.30%). Insiders that own company stock include Mark J Tarr, Douglas E Coltharp, John Patrick Darby, Andrew L Price, Elissa Joy Charbonneau, Greg D Carmichael and Kevin J O'connor.
View institutional ownership trends
.

Shares of EHC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Encompass Health investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), Advanced Micro Devices (AMD), Adobe (ADBE), ServiceNow (NOW) and Arista Networks (ANET).

Company Calendar

Record date for 4/15 Dividend
4/01/2025
Ex-Dividend for 4/15 Dividend
4/01/2025
Dividend Payable
4/15/2025
Last Earnings
4/24/2025
Today
4/25/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Hospitals
Sub-Industry
Health Care Facilities
Current Symbol
NYSE:EHC
Employees
35,000
Year Founded
1984

Price Target and Rating

Average Stock Price Target
$110.88
High Stock Price Target
$129.00
Low Stock Price Target
$95.00
Potential Upside/Downside
-2.2%
Consensus Rating
Buy
Rating Score (0-4)
3.20
Research Coverage
10 Analysts

Profitability

Trailing P/E Ratio
25.41
Forward P/E Ratio
23.61
P/E Growth
2.31
Net Income
$455.70 million
Pretax Margin
13.95%

Debt

Sales & Book Value

Annual Sales
$5.37 billion
Cash Flow
$8.58 per share
Price / Cash Flow
13.21
Book Value
$27.72 per share
Price / Book
4.09

Miscellaneous

Free Float
98,634,000
Market Cap
$11.41 billion
Optionable
Optionable
Beta
0.87

Social Links

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (NYSE:EHC) was last updated on 4/26/2025 by MarketBeat.com Staff
From Our Partners